Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10401135 | 0.81 | HSD17B10 (0.37) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL8329867 | 0.81 | HSD17B10 (0.37) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL27328375 | 0.71 | ALDH1A1 (0.38) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL1417466 | 0.70 | GABRA5 (0.47) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL27851070 | 0.70 | GABRA5 (0.43) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL27622470 | 0.69 | GABRA5 (0.40) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL1000856 | 0.69 | ALDH1A1 (0.44) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL9055334 | 0.69 | ALDH1A1 (0.36) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| SCHEMBL5298283 | 0.69 | ALDH1A1 (0.36) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL27328374 | 0.68 | ALDH1A1 (0.38) | HSD17B10GABRA5GABRB2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546154-A4 | PROCESS FOR THE PREPARATION OF CEFDINIR | RANBAXY LAB LTD (IN) | 2008-03-26 | — | — | EP | disclosed |
| US-20060040915-A1 | Process for the preparation of cefdinir | RANBAXY LABORATORIES LIMITED (IN) | 2006-02-23 | — | — | US | disclosed |
| EP-1546154-A1 | PROCESS FOR THE PREPARATION OF CEFDINIR | RANBAXY LABORATORIES, LTD. (IN) | 2005-06-29 | — | — | EP | disclosed |
| WO-2003091261-A1 | PROCESS FOR THE PREPARATION OF CEFDINIR | RANBAXY LABORATORIES LIMITED (IN) | 2003-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060040915-A1 | Process for the preparation of cefdinir | DCXR, C1R, PEPD | HSD17B10 485/4885GABRA5 957/4885GABRB2 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.